Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Margel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Harefuah|August 26, 2000
[Blunt trauma to the thoracic aorta]Y Kluger, D Margel, I Yerachimov, et al.
The Israel Medical Association Journal : IMAJ|April 25, 2000
Appendicitis in the elderly: what has changed?R Rub, D Margel, D Soffer, et al.
International Journal of Impotence Research|October 29, 2004
Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatmentD Margel, R Tal, P M Livne, et al.
Diseases of the Colon and Rectum|May 29, 2000
Transanal endoscopic microsurgery: experience with 75 rectal neoplasmsD Lev-Chelouche, D Margel, G Goldman, et al.
The Journal of Urology|June 16, 2007
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trialY Ehrlich, O Yossepowitch, D Margel, et al.
Journal of Endourology|August 15, 2006
Retrograde intrarenal surgery as second-line therapy yields a lower success rateR Holland, D Margel, P M Livne, et al.
Urology|January 18, 2006
Clinical implication of routine stone culture in percutaneous nephrolithotomy--a prospective studyD Margel, Y Ehrlich, N Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 22, 2020
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screeningN Segal, Y Ber, O Benjaminov, et al.
Breast Cancer Research and Treatment|May 27, 2016
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutationsR Lewin, A Sulkes, T Shochat, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical CystectomyP J Boström, J Thoms, J Sykes, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Harefuah|August 26, 2000
[Blunt trauma to the thoracic aorta]Y Kluger, D Margel, I Yerachimov, et al.
The Israel Medical Association Journal : IMAJ|April 25, 2000
Appendicitis in the elderly: what has changed?R Rub, D Margel, D Soffer, et al.
International Journal of Impotence Research|October 29, 2004
Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatmentD Margel, R Tal, P M Livne, et al.
Diseases of the Colon and Rectum|May 29, 2000
Transanal endoscopic microsurgery: experience with 75 rectal neoplasmsD Lev-Chelouche, D Margel, G Goldman, et al.
The Journal of Urology|June 16, 2007
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trialY Ehrlich, O Yossepowitch, D Margel, et al.
Journal of Endourology|August 15, 2006
Retrograde intrarenal surgery as second-line therapy yields a lower success rateR Holland, D Margel, P M Livne, et al.
Urology|January 18, 2006
Clinical implication of routine stone culture in percutaneous nephrolithotomy--a prospective studyD Margel, Y Ehrlich, N Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 22, 2020
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screeningN Segal, Y Ber, O Benjaminov, et al.
Breast Cancer Research and Treatment|May 27, 2016
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutationsR Lewin, A Sulkes, T Shochat, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical CystectomyP J Boström, J Thoms, J Sykes, et al.
Pageof 1